Inventor · disambiguated record
Klaus-Ulrich Weithmann
Also filed as: WEITHMANN KLAUES U · WEITHMANN KLAUS U · WEITHMANN KLAUS-ULRICH
34 granted patents·2 pending applications·493 citations·filing 1981–2007
97Inventor score
Top patents by PatentIndex Score
36 records- 0190US5508275ALipid-selective antioxidants and their preparation and useHOECHST AG·Filed 1994·Granted Apr 16, 1996·39 cites·13 claims
- 0286US5318987ALipid-selective antioxidants and their preparation and useHOECHST AG·Filed 1991·Granted Jun 7, 1994·27 cites·3 claims
- 0386US5043328AFormulations containing unsaturated fatty acids for the synthesis of prostaglandins and hydroxy-fatty acids in biological systemsHOECHST AG·Filed 1989·Granted Aug 27, 1991·41 cites·16 claims
- 0483US6159988AArylcycloalkyl derivatives, their production and their useHOECHST AG·Filed 1998·Granted Dec 12, 2000·33 cites·7 claims
- 0582US6573277B2Cyclic and heterocyclic N-substituted α-iminohydroxamic and -carboxylic acidsFiled 2001·Granted Jun 3, 2003·15 cites·11 claims
- 0682US4880791ACombination product composed of xanthine derivatives and O-acetylsalicylic acid or its pharmacologically tolerated salts, and its useHOECHST AG·Filed 1988·Granted Nov 14, 1989·27 cites·20 claims
- 0780US6815440B2Cyclic and heterocyclic N-substituted α-iminohydroxamic and -carboxylic acidsAVENTIS PHARMA GMBH·Filed 2003·Granted Nov 9, 2004·12 cites·19 claims
- 0875US5814627A3, 5-disubstituted and 3, 4, 5-trisubstituted 2-isoxazolines and isoxazoles, process for their preparation and their use as pharmaceuticalsHOECHST AG·Filed 1995·Granted Sep 29, 1998·40 cites·12 claims
- 0974US7166609B2Pyrimidine-4,6-dicarboxylic acid diamides for selectively inhibiting collagenasesSANOFI AVENTIS DEUTSCHLAND·Filed 2003·Granted Jan 23, 2007·7 cites·8 claims
- 1074US4975432AMethod of using pentoxifylline for treating inflammationHOECHST AG·Filed 1989·Granted Dec 4, 1990·15 cites·1 claims
- 1173US4850489ADispensing packs containing pharmaceutical combinations for sequential administrationHOECHST AG·Filed 1988·Granted Jul 25, 1989·41 cites·11 claims
- 1271US6207672B1Cyclic and heterocyclic N-substituted α-iminohydroxamic and carboxyclic acidsAVENTIS PHARMA GMBH·Filed 1996·Granted Mar 27, 2001·25 cites·12 claims
- 1369US5776977AArylcycloalkyl derivatives, their production and their useHOECHST AG·Filed 1996·Granted Jul 7, 1998·26 cites·9 claims
- 1469US4694024ACombination product composed of pyrimido-pyrimidines and O-acetylsalicylic acid or its pharmacologically tolerated salts, and its useHOECHST AG·Filed 1985·Granted Sep 15, 1987·14 cites·18 claims
- 1566US6933298B2Pyridine-2,4-dicarboxylic acid diamides and pyrimidine-4,6-dicarboxylic acid diamides and the use thereof for selectively inhibiting collagenasesAVENTIS PHARMA GMBH·Filed 2002·Granted Aug 23, 2005·3 cites·17 claims
- 1666US6337411B2Stromelysin inhibitorsAVENTIS PHARMA GMBH·Filed 2000·Granted Jan 8, 2002·3 cites·24 claims
- 1766US5589514AArylcycloalkyl derivatives, their production and their useHOECHST AG·Filed 1995·Granted Dec 31, 1996·21 cites·4 claims
- 1863US6716853B2Cyclic N-substituted alpha-imino carboxylic acids for selective inhibition of collogenaseAVENTIS PHARMA GMBH·Filed 2003·Granted Apr 6, 2004·2 cites·22 claims
- 1963US6503934B2Substituted thiadiazolesulfonamidesAVENTIS PHARMA GMBH·Filed 2001·Granted Jan 7, 2003·1 cites·10 claims
- 2058US5547970AUse of leflunomide for inhibiting tumor necrosis factor alphaHOECHST AG·Filed 1995·Granted Aug 20, 1996·14 cites·1 claims
- 2157US5137897A2-substituted 4-(3-alkyl-5-tert.-butyl-4-hydroxyphenyl) thiazoles, processes for their preparation, pharmaceuticals containing them and their useHOECHST AG·Filed 1990·Granted Aug 11, 1992·13 cites·8 claims
- 2257US4983514AMethod for detecting the antiaggregatory effect of vasoactive substances, specifically of inhibitors of phosphodiesterase and/or cyclooxygenaseHOECHST AG·Filed 1988·Granted Jan 8, 1991·15 cites·10 claims
- 2356US6218412B1Substituted thiadiazolesulfonamidesAVENTIS PHARMA GMBH·Filed 1999·Granted Apr 17, 2001·11 cites·16 claims
- 2455US5556870AUse of leflunomide for inhibiting interleukin 1 betaHOECHST AG·Filed 1995·Granted Sep 17, 1996·12 cites·1 claims
- 2553US5627173APhosphonoacetic acid derivatives and their use for treating degenerative joint disordersHOECHST AG·Filed 1996·Granted May 6, 1997·13 cites·32 claims
- 2650US6500811B2Sulfonylaminophosphinic and sulfonylaminophosphonic acid derivatives, methods for their preparation and useAVENTIS PHARMA GMBH·Filed 2001·Granted Dec 31, 2002·0 cites·24 claims
- 2750US5547971AUse of leflunomide for inhibiting interleukin 8HOECHST AG·Filed 1995·Granted Aug 20, 1996·8 cites·1 claims
- 2848US5504084APharmaceutical for the treatment of skin disordersHOECHST AG·Filed 1994·Granted Apr 2, 1996·7 cites·16 claims
- 2946US7652143B2Cyclic ureas used as inhibitors of metalloproteasesSANOFI AVENTIS DEUTSCHLAND·Filed 2007·Granted Jan 26, 2010·0 cites·2 claims
- 3044US6235727B1Sulfonylaminophosphinic and sulfonylaminophosphinic acid derivatives, methods for their preparation and useAVENTIS PHARMA GMBH·Filed 1999·Granted May 22, 2001·4 cites·22 claims
- 3142US4904648APharmaceutical preparations for induction of labor and for contraceptive useHOECHST AG·Filed 1989·Granted Feb 27, 1990·2 cites·16 claims
- 3241US6737246B2Method for detecting protein inhibitors and ligands of medical valueAVENTIS PHARMA GMBH·Filed 2001·Granted May 18, 2004·0 cites·2 claims
- 3341US2005004111A1Selective MMP-13 inhibitorsAVENTIS PHARMA GMBH·Filed 2004·Application pending·0 cites
- 3435US5554637AUse of leflunomide for inhibiting interleukin 1 alphaHOECHST AG·Filed 1995·Granted Sep 10, 1996·1 cites·1 claims
- 3535US2009149332A1Methods for determining the activity of adam-ts proteases using thiopeptolidesSANOFI AVENTIS DEUTSCHLAND·Filed 2006·Application pending·0 cites
- 3632US4333948APharmaceutical formulations containing prostaglandinHOECHST AG·Filed 1981·Granted Jun 8, 1982·1 cites·8 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →